On December 7, 2023, David Botstein, a member of the board of directors of Pacific Biosciences of California, Inc. (the Company), notified the Company of his resignation from the Board, effective immediately. The Company is not aware of any disagreement between Mr. Botstein and the Company on any matter relating to the Company?s operations, policies or practices that resulted in Mr. Botstein?s resignation.
Pacific Biosciences of California, Inc.
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | +6.52% | -5.16% | -85.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.02% | 400M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.
- Pacific Biosciences of California, Inc. Announces Resignation of David Botstein from the Board